337 related articles for article (PubMed ID: 33492286)
41. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.
Whitwell JL; Josephs KA; Murray ME; Kantarci K; Przybelski SA; Weigand SD; Vemuri P; Senjem ML; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW; Jack CR
Neurology; 2008 Sep; 71(10):743-9. PubMed ID: 18765650
[TBL] [Abstract][Full Text] [Related]
42. Sum of boxes of the clinical dementia rating scale highly predicts conversion or reversion in predementia stages.
Tzeng RC; Yang YW; Hsu KC; Chang HT; Chiu PY
Front Aging Neurosci; 2022; 14():1021792. PubMed ID: 36212036
[TBL] [Abstract][Full Text] [Related]
43. Temporal unfolding of declining episodic memory on the Free and Cued Selective Reminding Test in the predementia phase of Alzheimer's disease: Implications for clinical trials.
Grober E; Veroff AE; Lipton RB
Alzheimers Dement (Amst); 2018; 10():161-171. PubMed ID: 29552631
[TBL] [Abstract][Full Text] [Related]
44. Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy Cohort.
Pillai JA; Butler RS; Bonner-Jackson A; Leverenz JB
Dement Geriatr Cogn Disord; 2016; 42(1-2):106-16. PubMed ID: 27623397
[TBL] [Abstract][Full Text] [Related]
45. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
[TBL] [Abstract][Full Text] [Related]
46. Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system.
Grober E; Papp KV; Rentz DM; Sperling RA; Johnson KA; Amariglio RE; Schultz A; Lipton RB; Ezzati A
Alzheimers Dement (Amst); 2021; 13(1):e12224. PubMed ID: 35005192
[TBL] [Abstract][Full Text] [Related]
47. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.
Gosche KM; Mortimer JA; Smith CD; Markesbery WR; Snowdon DA
Neurology; 2002 May; 58(10):1476-82. PubMed ID: 12034782
[TBL] [Abstract][Full Text] [Related]
48. Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study.
Mortimer JA; Gosche KM; Riley KP; Markesbery WR; Snowdon DA
Neurology; 2004 Feb; 62(3):428-32. PubMed ID: 14872025
[TBL] [Abstract][Full Text] [Related]
49. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia.
Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
Neurology; 2007 Mar; 68(12):927-31. PubMed ID: 17372128
[TBL] [Abstract][Full Text] [Related]
50. Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic features.
Qiu Y; Jacobs DM; Messer K; Salmon DP; Feldman HH
Neurology; 2019 Aug; 93(8):e778-e790. PubMed ID: 31320469
[TBL] [Abstract][Full Text] [Related]
51. Total cost of care increases significantly from early to mild Alzheimer's disease: 5-year ALSOVA follow-up.
Jetsonen V; Kuvaja-Köllner V; Välimäki T; Selander T; Martikainen J; Koivisto AM
Age Ageing; 2021 Nov; 50(6):2116-2122. PubMed ID: 34255025
[TBL] [Abstract][Full Text] [Related]
52. Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials.
Cedarbaum JM; Jaros M; Hernandez C; Coley N; Andrieu S; Grundman M; Vellas B;
Alzheimers Dement; 2013 Feb; 9(1 Suppl):S45-55. PubMed ID: 22658286
[TBL] [Abstract][Full Text] [Related]
53. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.
Bierer LM; Hof PR; Purohit DP; Carlin L; Schmeidler J; Davis KL; Perl DP
Arch Neurol; 1995 Jan; 52(1):81-8. PubMed ID: 7826280
[TBL] [Abstract][Full Text] [Related]
54. Operational Determination of Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia Using Sum of Boxes of the Clinical Dementia Rating Scale.
Yang YW; Hsu KC; Wei CY; Tzeng RC; Chiu PY
Front Aging Neurosci; 2021; 13():705782. PubMed ID: 34557083
[No Abstract] [Full Text] [Related]
55. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
[TBL] [Abstract][Full Text] [Related]
56. Minimal clinically important difference in Alzheimer's disease: Rapid review.
Muir RT; Hill MD; Black SE; Smith EE
Alzheimers Dement; 2024 May; 20(5):3352-3363. PubMed ID: 38561021
[TBL] [Abstract][Full Text] [Related]
57. The Use of the Clinical Dementia Rating Scale Sum of Boxes Scores in Detecting and Staging Cognitive Impairment/Dementia in Brazilian Patients With Low Educational Attainment.
Lima APV; Castilhos R; Chaves MLF
Alzheimer Dis Assoc Disord; 2017; 31(4):322-327. PubMed ID: 28700383
[TBL] [Abstract][Full Text] [Related]
58. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
Matsuda A; Kazui H; Hirono N; Mori E
No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
[TBL] [Abstract][Full Text] [Related]
59. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
60. Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.
Haaksma ML; Calderón-Larrañaga A; Olde Rikkert MGM; Melis RJF; Leoutsakos JS
Int J Geriatr Psychiatry; 2018 Aug; 33(8):1057-1064. PubMed ID: 29761569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
